Movatterモバイル変換

Jump to content

esketamine(Q2365493)

From Wikidata

chemical compound

(-)-ketamine
(S)-(-)-ketamine
(S)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone
(S)-ketamine

Language	Label	Description	Also known as
default for all languages	No label defined
English	esketamine	chemical compound	(-)-ketamine (S)-(-)-ketamine (S)-2-(o-chlorophenyl)-2-(methylamino)cyclohexanone (S)-ketamine

Statements

type of chemical entity

0 references

0 references

0 references

chemical structure

Esketamine.svg
723 × 702; 11 KB

0 references

237.092042dalton

1 reference

language of work or name

Esketamine(English)

3 October 2016

stereoisomer of

2 references

based on heuristic

inferred from InChIKey

based on heuristic

inferred from InChI

chemical formula

C₁₃H₁₆ClNO

1 reference

language of work or name

Esketamine(English)

3 October 2016

canonical SMILES

CNC1(CCCCC1=O)C2=CC=CC=C2Cl

1 reference

language of work or name

Esketamine(English)

3 October 2016

isomeric SMILES

CN[C@@]1(CCCCC1=O)C2=CC=CC=C2Cl

1 reference

language of work or name

Esketamine(English)

3 October 2016

active ingredient in

0 references

World Health Organisation international non-proprietary name

esketamine(English)

1 reference

language of work or name

esketamine(English)

3 October 2016

medical condition treated

treatment-resistant depression

0 references

physically interacts with

Glutamate ionotropic receptor NMDA type subunit 2D

subject has role

negative allosteric modulator

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL395091

Glutamate ionotropic receptor NMDA type subunit 3A

subject has role

negative allosteric modulator

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL395091

Glutamate ionotropic receptor NMDA type subunit 2C

subject has role

negative allosteric modulator

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL395091

Glutamate ionotropic receptor NMDA type subunit 2A

subject has role

negative allosteric modulator

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL395091

Glutamate ionotropic receptor NMDA type subunit 1

subject has role

negative allosteric modulator

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL395091

Glutamate ionotropic receptor NMDA type subunit 2B

subject has role

negative allosteric modulator

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL395091

chemical structure differs in the spatial configuration of at least one stereogenic center

0 references

Commons category

Esketamine

0 references

Identifiers

InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1

1 reference

language of work or name

Esketamine(English)

3 October 2016

YQEZLKZALYSWHR-ZDUSSCGKSA-N

2 references

language of work or name

Esketamine(English)

3 October 2016

ChEBI release 2020-09-01

CAS Registry Number

2 references

language of work or name

esketamine(English)

3 October 2016

YQEZLKZALYSWHR-ZDUSSCGKSA-N

CAS Common Chemistry

8 April 2021

https://commonchemistry.cas.org/detail?cas_rn=33643-46-8

1 reference

language of work or name

Esketamine(English)

3 October 2016

2 references

language of work or name

Esketamine(English)

3 October 2016

matched by identifier from

YQEZLKZALYSWHR-ZDUSSCGKSA-N

Reaxys registry number

4295313

1 reference

language of work or name

esketamine(English)

3 October 2016

mapping relation type

2 references

language of work or name

esketamine(English)

3 October 2016

matched by identifier from

International Chemical Identifier

InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3/t13-/m0/s1

1 reference

language of work or name

ESKETAMINE(English)

3 October 2016

2 references

based on heuristic

inferred from InChIKey

matched by identifier from

YQEZLKZALYSWHR-ZDUSSCGKSA-N

UniChem compound ID

1 reference

DSSTox substance ID

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

matched by identifier from

YQEZLKZALYSWHR-ZDUSSCGKSA-N

DSSTOX compound identifier

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

(2S)-2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one(English)

CAS no.: 33643-46-8(English)

ECHA Substance Infocard ID

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

20 December 2018

(2S)-2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one(English)

CAS no.: 33643-46-8(English)

0 references

Guide to Pharmacology Ligand ID

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

language of work or name

esketamine(English)

3 October 2016

0 references

1 reference

matched by identifier from

YQEZLKZALYSWHR-ZDUSSCGKSA-N

2 references

Global Substance Registration System

language of work or name

ESKETAMINE(English)

3 October 2016

matched by identifier from

YQEZLKZALYSWHR-ZDUSSCGKSA-N

MedlinePlus drug identifier

0 references

Probes And Drugs ID

0 references

1 reference

1 reference

language of work or name

esketamine(English)

3 October 2016

0 references

Microsoft Academic ID

0 references

UK Parliament thesaurus ID

subject named as

Esketamine

0 references

WikiProjectMed ID

0 references

subject named as

esketamiini

esketamin

esketamine

1 reference

YSO-Wikidata mapping project

28 January 2022

Sitelinks

Wikipedia(17 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

commonswikiCategory:Esketamine

Retrieved from "https://www.wikidata.org/w/index.php?title=Q2365493&oldid=2321704466"

[8]ページ先頭

©2009-2025 Movatter.jp